Increasingly, RNA-associated variants are being recognized as clinically relevant within the analysis of non-small cell lung cancer specimens
Rather than conducting individual, sequential tests to identify these variants, RNA-seq enables the massively parallel sequencing of samples to detect these variants in a single run from a small specimen. This poster describes how the QuantideX NGS RNA Lung Cancer Kit enables the highly sensitive, specific, and reproducible detection of RNA fusions and exon-skipping events from precious FFPE tumor specimens.
The QuantideX NGS RNA Lung Cancer Kit is for research use only.
Offered Free by: Asuragen
See All Resources from: Asuragen
This download should complete shortly. If the resource doesn't automatically download, please, click here.